Lue Dai is a seasoned scientist and inventor in the field of drug discovery, currently serving as the Head of Discovery Biology at RiboX Therapeutics since 2022. They previously held positions as a Senior Scientist and Project Leader at Roche from 2015 to 2021, and as a Principal Scientist at Roche from 2019 to 2021. Earlier in their career, Lue completed a postdoctoral fellowship at SAIC-Frederick, NCI/NIAID, NIH, where they contributed significantly to research on IL-27 and its antiviral properties. Lue earned a Ph.D. from the University of Massachusetts Medical School, where they focused on HIV-related studies.
This person is not in the org chart
This person is not in any teams
This person is not in any offices